CV Sciences, Inc. (CVSI)
OTCMKTS
· Delayed Price · Currency is USD
0.0465
+0.0013 (2.88%)
Sep 16, 2024, 3:13 PM EDT
CV Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 15.85 | 16 | 16.21 | 20.05 | 24.43 | 53.7 | Upgrade
|
| Revenue Growth (YoY) | 0.71% | -1.24% | -19.17% | -17.93% | -54.50% | 11.30% | Upgrade
|
| Cost of Revenue | 8.55 | 8.92 | 10.66 | 11.43 | 13.42 | 18.61 | Upgrade
|
| Gross Profit | 7.3 | 7.09 | 5.55 | 8.62 | 11.01 | 35.09 | Upgrade
|
| Selling, General & Admin | 9.03 | 9.49 | 13.37 | 20.84 | 30.66 | 35.34 | Upgrade
|
| Research & Development | 0.14 | 0.15 | 0.31 | 1.19 | 2.94 | 5.88 | Upgrade
|
| Other Operating Expenses | - | -6.17 | - | - | - | - | Upgrade
|
| Operating Expenses | 9.18 | 3.47 | 13.68 | 22.03 | 33.6 | 41.21 | Upgrade
|
| Operating Income | -1.88 | 3.61 | -8.13 | -13.41 | -22.59 | -6.12 | Upgrade
|
| Interest Expense | - | -0.06 | -1.54 | -0.14 | -0.01 | - | Upgrade
|
| Interest & Investment Income | 0 | - | - | - | - | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0.2 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -1.88 | 3.35 | -9.67 | -13.55 | -22.6 | -6.11 | Upgrade
|
| Impairment of Goodwill | - | - | - | -2.79 | - | - | Upgrade
|
| Legal Settlements | -0.4 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 1.72 | 2.95 | - | -11.12 | Upgrade
|
| Pretax Income | -2.53 | 3.1 | -9.18 | -15.64 | -22.6 | -17.23 | Upgrade
|
| Income Tax Expense | -0 | -0.01 | -0.05 | -0.09 | -0.32 | -0.62 | Upgrade
|
| Net Income | -2.53 | 3.1 | -9.13 | -15.55 | -22.28 | -16.61 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | 0.92 | - | - | - | Upgrade
|
| Net Income to Common | -2.53 | 3.1 | -10.05 | -15.55 | -22.28 | -16.61 | Upgrade
|
| Shares Outstanding (Basic) | 162 | 154 | 138 | 108 | 100 | 98 | Upgrade
|
| Shares Outstanding (Diluted) | 162 | 154 | 138 | 108 | 100 | 98 | Upgrade
|
| Shares Change (YoY) | 7.32% | 11.53% | 28.03% | 7.91% | 2.10% | -14.51% | Upgrade
|
| EPS (Basic) | -0.02 | 0.02 | -0.07 | -0.14 | -0.22 | -0.17 | Upgrade
|
| EPS (Diluted) | -0.02 | 0.02 | -0.07 | -0.14 | -0.22 | -0.17 | Upgrade
|
| Free Cash Flow | -0.71 | 2.25 | -1.89 | -7.52 | -8.36 | -3.37 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.01 | -0.01 | -0.07 | -0.08 | -0.03 | Upgrade
|
| Gross Margin | 46.06% | 44.27% | 34.25% | 42.98% | 45.07% | 65.35% | Upgrade
|
| Operating Margin | -11.85% | 22.56% | -50.16% | -66.90% | -92.48% | -11.40% | Upgrade
|
| Profit Margin | -15.95% | 19.38% | -62.04% | -77.58% | -91.22% | -30.93% | Upgrade
|
| Free Cash Flow Margin | -4.47% | 14.08% | -11.63% | -37.51% | -34.21% | -6.28% | Upgrade
|
| EBITDA | -1.62 | 3.85 | -7.14 | -12.26 | -21.72 | -5.41 | Upgrade
|
| EBITDA Margin | -10.24% | 24.03% | -44.04% | -61.15% | -88.91% | -10.07% | Upgrade
|
| D&A For EBITDA | 0.26 | 0.24 | 0.99 | 1.15 | 0.87 | 0.72 | Upgrade
|
| EBIT | -1.88 | 3.61 | -8.13 | -13.41 | -22.59 | -6.12 | Upgrade
|
| EBIT Margin | -11.85% | 22.56% | -50.16% | -66.90% | -92.48% | -11.40% | Upgrade
|
| Advertising Expenses | - | 1.1 | 1.2 | 1.3 | 1.3 | 2.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.